Position in REGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$212,627
-$46,980 QoQ
Shares Held
341
+1.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#1,034
of 1,322 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Green Alpha Advisors, LLC holds $9,323,372 across 14 Biotechnology names. REGN ranks #10 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
55,804 | $3,043,550 | |
| 2 | MRNA |
Moderna, Inc.
|
33,758 | $2,364,072 | |
| 3 | PRME |
Prime Medicine, Inc.
|
185,023 | $682,734 | |
| 4 | CRBU |
Caribou Biosciences, Inc.
|
364,324 | $641,210 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
|
147,544 | $541,486 | |
| 6 | EDIT |
Editas Medicine, Inc.
|
156,046 | $505,589 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
552 | $274,194 | |
| 8 | BEAM |
Beam Therapeutics Inc.
|
7,569 | $259,768 |
All Filings in REGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $212,627 | 341 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $259,607 | 336 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $294,082 | 381 | Shares | Sole | 2026-01-07 | |
| 2025-03-31 | $218,175 | 344 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $255,014 | 358 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $401,573 | 382 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $437,228 | 416 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $450,445 | 468 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $404,891 | 461 | Shares | Sole | 2024-01-05 | |
| 2023-09-30 | $437,814 | 532 | Shares | Sole | 2023-10-10 | |
| No filing history on record for this holder in this stock. | ||||||